Annual balance sheet for Lihit Lab, fiscal year end - February 28th, JPY millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | 2026 February 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | — | — | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2,260 | 1,077 | 1,243 | 2,332 | 729 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,651 | 1,766 | 1,729 | 1,829 | 2,071 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,550 | 6,025 | 5,746 | 7,206 | 5,724 |
| Net Property, Plant And Equipment | 5,360 | 5,208 | 5,810 | 4,659 | 5,806 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 13,330 | 12,732 | 13,118 | 13,432 | 13,516 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,311 | 785 | 1,081 | 1,302 | 1,054 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,219 | 2,512 | 2,875 | 2,795 | 2,537 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 10,110 | 10,220 | 10,242 | 10,637 | 10,979 |
| Total Liabilities & Shareholders' Equity | 13,330 | 12,732 | 13,118 | 13,432 | 13,516 |
| Total Common Shares Outstanding |